2014 Highlights of ASH in North America Meeting

Emerging effective treatment options for salvage therapy in Hodgkin lymphoma were described by Anas Younes, MD, Chief of the Lymphoma Service at Memorial Sloan Kettering Cancer Center, New York, at th...

myelodysplastic syndromes

Caroline Helwick / May 15, 2014 / 2014 Highlights of ASH in North America Meeting

Forward Progress in Myelodysplastic Syndromes Is Largely in Genetics

Most recent advances in the management of myelodysplastic syndrome (MDS) are in the area of genetics, according to Steven Gore, MD, of Yale University School of Medicine, New Haven. “New genomics res...

Jul

Today In Oncology

NCI and VA Launch NAVIGATE to Boost Veterans’ Access to Cancer Clinical Trials

Palliative Care Preferences in Male Patients With Cancer

Human Papillomavirus Vaccine in Cutaneous Basaloid Squamous Cell Carcinomas

ASCO Clinical Practice Guideline Update: Systemic Therapy for Patients With Advanced HER2-Positive Breast Cancer

AR-V7 as Marker for Taxane vs Androgen Receptor Inhibitor Treatment in Castration-Resistant Prostate Cancer

;

2014 Highlights of ASH in North America Meeting

Better Options Emerging for Salvage Therapy in Hodgkin Lymphoma

Forward Progress in Myelodysplastic Syndromes Is Largely in Genetics

NCI and VA Launch NAVIGATE to Boost Veterans’ Access to Cancer Clinical Trials

Palliative Care Preferences in Male Patients With Cancer

Human Papillomavirus Vaccine in Cutaneous Basaloid Squamous Cell Carcinomas

ASCO Clinical Practice Guideline Update: Systemic Therapy for Patients With Advanced HER2-Positive Breast Cancer

AR-V7 as Marker for Taxane vs Androgen Receptor Inhibitor Treatment in Castration-Resistant Prostate Cancer

FDA Accepts sBLA for Pembrolizumab in Combination With Chemotherapy as First-Line Treatment for Metastatic Squamous NSCLC

Intratumoral Recombinant Poliovirus in Grade IV Glioblastoma

Raising Awareness of the Financial Impact of Cancer on Young Adult Survivors

ASCO Clinical Practice Guideline Update: Disease Management for Patients With Advanced HER2-Positive Breast Cancer and Brain Metastases

Testicular Cancer Survivors and Adequate Screening for Long-Term Heart Disease

Toni K. Choueiri, MD, and Jonathan E. Rosenberg, MD: Bladder Cancer Roundup

A. Oliver Sartor, MD, on Issues in Immunotherapy

Toni K. Choueiri, MD, and Lauren C. Harshman, MD on RCC: Results From the PROSPER Trial

Andrew D. Seidman, MD, on Embracing Computer-Assisted Decision-Making

William G. Wierda, MD, PhD, and Julie M. Vose, MD, MBA, on CLL: Results From the CAPTIVATE Trial